Loreen Willenberg, HIV Advocate and Potential Cure Case, Dies at 66
Loreen Willenberg, a pioneering HIV advocate and “elite controller” whose unique immune response advanced HIV cure research, died on April 7, 2026, at the age of 66. Her willingness to participate in research and openly share her experiences as someone living with HIV, yet able to control the virus without medication, significantly impacted the field.
Early Life and Diagnosis
Willenberg was diagnosed with HIV in 1992 while living in Placerville, California. Unlike most people living with HIV, she was able to maintain an undetectable viral load and a healthy immune cell count without ever needing antiretroviral therapy. This rare ability categorized her as an “exceptional elite controller.”
Advocacy and the Zephyr Foundation
In 2006, Willenberg became the first person to publicly identify as an elite controller, sharing her story to raise awareness and inspire hope. She founded the Zephyr Foundation that same year, creating an online resource for individuals who could spontaneously control HIV. For over two decades, she actively participated in public forums, served on community advisory boards, and contributed to numerous clinical HIV research studies. She believed in the importance of continued research, stating, “I still worry about the 40 million-plus people [living with HIV]…individuals who need to be on the medications,” and expressed her desire to “aid…in a really big way.” amfAR
Research and Potential Cure
Willenberg collaborated with researchers, including Drs. Xu Yu and Matthias Lichterfeld of the Ragon Institute of MGH, MIT, and Harvard. In 2020, their research found no intact HIV in her body after examining over one billion cells. Dr. Yu recently suggested that Willenberg may have been functionally cured of HIV. amfAR
Significance of Elite Controllers
Cases like Willenberg’s, and that of another woman dubbed the “Esperanza patient,” are particularly important because they offer insights into natural HIV control mechanisms. Researchers have found no replication-competent HIV genetic material in billions of cells from both women, only degraded sections of HIV DNA, indicating past infection but no ability to create new viruses. AIDSmap This contrasts with the two known HIV cures achieved through bone marrow transplants, which are dangerous and expensive procedures reserved for cancer patients.
Willenberg’s Legacy
Loreen Willenberg’s dedication to HIV research and advocacy leaves a lasting impact. Her willingness to share her experiences and her body to science has expanded the boundaries of HIV cure research and offered hope to millions living with the virus. She approached her participation in research with gratitude, stating, “And that’s why I walk in gratitude.” amfAR
Keep reading